Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06901245 · ClinicalTrials.gov registry record · Phase 4

Tirzepatide in PWS, HO and GNSO

A Phase 4 study of Prader-Willi Syndrome and Hypothalamic Obesity, sponsored by Grace Kim.

Recruiting
Registry status
Phase 4
Development phase
36
Enrollment target
3
Study locations

NCT06901245 is a Phase 4 study of Prader-Willi Syndrome and Hypothalamic Obesity that is actively recruiting participants, run by Grace Kim. The registered enrollment target is 36 participants, below the 69-participant average among 16 other Prader-Willi Syndrome trials with a reported enrollment target (48% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06901245, a Phase 4 study of Prader-Willi Syndrome and Hypothalamic Obesity, is actively recruiting participants, sponsored by Grace Kim.

RECRUITING
Registry status
Phase 4
Development phase
36 participants
Enrollment target
3
Study locations

Study Summary

This research study is comparing the effectiveness of a weight loss medication called Tirzepatide in young adults with Prader-Willi Syndrome and/or hypothalamic obesity, as compared to young adults with obesity that is unrelated to a genetic syndrome or underlying medical cause. These groups will be given medication for 1 year to see how weight and other health factors are effected by the medication.

Conditions Studied

Prader-Willi Syndrome Hypothalamic Obesity Obesity/Therapy

Interventions

  • DRUG Tirzepatide

Study Locations (3)

Minnesota

  • Children's Minnesota - Saint Paul

Tennessee

  • Vanderbilt University Medical Center - Nashville

Washington

  • Seattle Children's Hospital - Seattle

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2025-05-01
Est. Completion 2026-12
Phase Phase 4

Sponsor

Grace Kim

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06901245

The ClinicalTrials.gov registry entry for NCT06901245 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 69-participant average among 16 other Prader-Willi Syndrome trials with a reported enrollment target (48% lower). The listed sponsor is Grace Kim, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Prader-Willi Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Tirzepatide is the first listed.

NCT06901245 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Minnesota, Tennessee, Washington.

Frequently Asked Questions

What is clinical trial NCT06901245 about?

NCT06901245 is a clinical study titled "Tirzepatide in PWS, HO and GNSO". This research study is comparing the effectiveness of a weight loss medication called Tirzepatide in young adults with Prader-Willi Syndrome and/or hypothalamic obesity, as compared to young adults with obesity that is unrelated to a genetic syndrome or underlying medical cause. These groups will be...

What is the current status of trial NCT06901245?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2025-05-01. Estimated completion is 2026-12.

What conditions does trial NCT06901245 study?

This clinical trial studies the following conditions: Prader-Willi Syndrome, Hypothalamic Obesity, Obesity/Therapy.

What interventions are being tested in trial NCT06901245?

The interventions under investigation include: Tirzepatide (DRUG).

Who is sponsoring clinical trial NCT06901245?

This trial is sponsored by Grace Kim, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06901245 being conducted?

This trial has 3 study locations across Minnesota, Tennessee, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prader-Willi Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prader-Willi Syndrome

All registered trials for this condition

Hypothalamic Obesity

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.